Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 20 results.
User Information
Export Records
  1. 1.   Evaluation of an antibody to a4ß7 in the control of SIVmac239-nef-stop infection
  2. Di Mascio, M; Lifson,Jeffrey; Srinivasula,Sharat; Kim,Insook; DeGrange, P; Keele,Brandon; Belli, A J; Reimann, K A; Wang, Y; Proschan, M; Lane, H C; Fauci, A S
  3. Science (New York, N.Y.). 2019, Sep 06; 365(6457): 1025-1029.
  1. 2.   HSV-2 Infection of Dendritic Cells Amplifies a Highly Susceptible HIV-1 Cell Target
  2. Martinelli, E.; Tharinger, H.; Frank, I.; Arthos, J.; Piatak, M.; Lifson, J. D.; Blanchard, J.; Gettie, A.; Robbiani, M.
  3. Plos Pathogens. 2011, Jun; 7(6): 14.
  1. 3.   Cutting Edge: A Critical Role for the G Protein-Coupled Receptor mFPR2 in Airway Inflammation and Immune Responses
  2. Chen, K. Q.; Le, Y. Y.; Liu, Y.; Gong, W. H.; Ying, G. G.; Huang, J.; Yoshimura, T.; Tessarollo, L.; Wang, J. M.
  3. Journal of Immunology. 2010, Apr; 184(7): 3331-3335.
  1. 4.   An engineered selenocysteine defines a unique class of antibody derivatives
  2. Hofer, T.; Thomas, J. D.; Burke, T. R.; Rader, C.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2008 105(34): 12451-12456.
  1. 5.   Application of a trifunctional reactive linker for the construction of antibody-drug hybrid conjugates
  2. Thomas, J. D.; Hofer, T.; Rader, C.; Burke, T. R.
  3. Bioorganic & Medicinal Chemistry Letters. 2008 18(21): 5785-5788.
  1. 6.   F2L, a peptide derived from heme-binding protein, chemoattracts mouse neutrophils by specifically activating Fpr2, the low-affmity N-formylpeptide receptor
  2. Gao, J. L.; Guillabert, A.; Hu, J. Y.; Le, Y. Y.; Urizar, E.; Seligman, E.; Fang, K. J.; Yuan, X.; Imbault, V.; Communi, D.; Wang, J. M.; Parmentier, M.; Murphy, P. M.; Migeotte, F.
  3. Journal of Immunology. 2007, Feb; 178(3): 1450-1456.
  1. 7.   Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as immune adjuvant
  2. Kurosaka, K.; Chen, Q.; Yarovinsky, F.; Oppenheim, J. J.; Yang, D.
  3. Journal of Immunology. 2005, MAY 15; 174(10): 6257-6265.
  1. 8.   The search for novel drug leads for predominately antitumor therapies by utilizing mother nature's pharmacophoric libraries
  2. Kingston, D. G. I.; Newman, D. J.
  3. Current Opinion in Drug Discovery & Development. 2005, MAR; 8(2): 207-227.
  1. 9.   Human dendritic cells express functional formyl peptide receptor-like-2 (FPRL2) throughout maturation
  2. Yang, D.; Chen, Q.; Gertz, B.; He, R.; Phulsuksombati, M.; Ye, R. D.; Oppenheim, J. J.
  3. Journal of Leukocyte Biology. 2002 72(3): 598-607.
  1. 10.   The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R
  2. Resnati, M.; Pallavicini, I.; Wang, J. M.; Oppenheim, J.; Serhan, C. N.; Romano, M.; Blasi, F.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2002 99(3): 1359-1364.
  1. 11.   Formyl-peptide receptors revisited
  2. Le, Y. Y.; Murphy, P. M.; Wang, J. M.
  3. Trends in Immunology. 2002 23(11): 541-548.
  1. 12.   Pleiotropic roles of formyl peptide receptors
  2. Le, Y. Y.; Oppenheim, J. J.; Wang, J. M.
  3. Cytokine & Growth Factor Reviews. 2001 12(1): 91-105.
  1. 13.   Differential regulation of formyl peptide receptor-like 1 expression during the differentiation of monocytes to dendritic cells and macrophages
  2. Yang, D.; Chen, Q.; Le, Y. Y.; Wang, J. M.; Oppenheim, J. J.
  3. Journal of Immunology. 2001 166(6): 4092-4098.
  1. 14.   Expression of functional formyl peptide receptors by human astrocytoma cell lines
  2. Le, Y. Y.; Hu, J. Y.; Gong, W. H.; Shen, W. P.; Li, B. Q.; Dunlop, N. M.; Halverson, D. O.; Blair, D. G.; Wang, J. M.
  3. Journal of Neuroimmunology. 2000 111(1-2): 102-108.
  1. 15.   Activation of the chemotactic peptide receptor FPRL1 in monocytes phosphorylates the chemokine receptor CCR5 and attenuates cell responses to selected chemokines
  2. Shen, W. P.; Proost, P.; Li, B. Q.; Gong, W. H.; Le, Y. Y.; Sargeant, R.; Murphy, P. M.; Van Damme, J.; Wang, J. M.
  3. Biochemical and Biophysical Research Communications. 2000 272(1): 276-283.
  1. 16.   Novel pathophysiological role of classical chemotactic peptide receptors and their communications with chemokine receptors
  2. Le, Y. Y.; Li, B. Q.; Gong, W. H.; Shen, W. P.; Hu, J. Y.; Dunlop, N. M.; Oppenheim, J. J.; Wang, J. M.
  3. Immunological Reviews. 2000 177: 185-194.
  1. 17.   Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation
  2. Le, Y. Y.; Gong, W. H.; Li, B. Q.; Dunlop, N. M.; Shen, W. P.; Su, S. B.; Ye, R. D.; Wang, J. M.
  3. Journal of Immunology. 1999 163(12): 6777-6784.
  1. 18.   T21/DP107, a synthetic leucine zipper-like domain of the HIV-1 envelope gp41, attracts and activates human phagocytes by using G-protein-coupled formyl peptide receptors
  2. Su, S. B.; Gao, J. L.; Gong, W. H.; Dunlop, N. M.; Murphy, P. M.; Oppenheim, J. J.; Wang, J. M.
  3. Journal of Immunology. 1999 162(10): 5924-5930.
  1. 19.   A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells
  2. Su, S. B.; Gong, W. H.; Gao, J. L.; Shen, W. P.; Murphy, P. M.; Oppenheim, J. J.; Wang, J. M.
  3. Journal of Experimental Medicine. 1999 189(2): 395-402.
  1. 20.   A synthetic peptide derived from human immunodeficiency virus type 1 gp120 downregulates the expression and function of chemokine receptors CCR5 and CXCR4 in monocytes by activating the 7-transmembrane G-protein-coupled receptor FPRL1/LXA4R
  2. Deng, X. Y.; Ueda, H.; Su, S. B.; Gong, W. H.; Dunlop, N. M.; Gao, J. L.; Murphy, P. M.; Wang, J. M.
  3. Blood. 1999 94(4): 1165-1173.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel